+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Lumbar Degenerative Disc Disease Market by Treatment (Epidural Steroid Injections (ESIs), Over-the-counter (OTC) Pain Medications, Therapy Devices), Route of Administration (Injectables, Oral), End-Users - Forecast 2024-2030- Product Image
Global Lumbar Degenerative Disc Disease Market by Treatment (Epidural Steroid Injections (ESIs), Over-the-counter (OTC) Pain Medications, Therapy Devices), Route of Administration (Injectables, Oral), End-Users - Forecast 2024-2030- Product Image
Sale

Global Lumbar Degenerative Disc Disease Market by Treatment (Epidural Steroid Injections (ESIs), Over-the-counter (OTC) Pain Medications, Therapy Devices), Route of Administration (Injectables, Oral), End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5944537
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lumbar Degenerative Disc Disease Market size was estimated at USD 744.58 million in 2023, USD 796.33 million in 2024, and is expected to grow at a CAGR of 7.15% to reach USD 1,207.76 million by 2030.

Lumbar degenerative disc disease (LDDD) is a condition impacting the lower spine that involves the loss of fluid, flexibility, and shock absorption capabilities in the intervertebral discs over time. These changes can lead to the discs' inability to cushion the lumbar vertebrae effectively, resulting in pain, instability, and reduced mobility. LDDD is a natural part of aging and can be exacerbated by factors such as genetics, lifestyle, and injury. With the rising number of elderly individuals worldwide, LDDD becomes more susceptible to degenerative conditions, leading to an increased need for treatments and therapies specifically targeting LDDD.

Increased awareness and education about LDDD among both patients and healthcare providers have led to higher diagnosis rates and a more proactive approach to management. This greater understanding of the disease encourages individuals to seek treatment sooner, thereby expanding the patient pool for LDDD therapies. Expansion in healthcare expenditure and improvements in insurance coverage for degenerative diseases are also expanding the accessibility of lumbar degenerative disc disease therapies. The high cost associated with advanced treatments and surgeries with LDDD hampers the market growth. The development of innovative diagnostic and treatment technologies has significantly contributed to the growth of the LDDD market. Improved imaging techniques, such as MRI and CT scans, allow for early and precise diagnosis, while advancements in surgical procedures and non-invasive treatments offer more effective management options for patients.

Regional Insights

The Americas represents a significant market for the lumbar degenerative disc disease market, primarily due to the higher incidence rates of spinal disorders, a well-established healthcare infrastructure, and leading medical device companies. Additionally, the aging population in the Americas further escalates the need for treatment options, making it a lucrative market for lumbar degenerative disc disease therapies and surgeries. Asia-Pacific region is the growing market for lumbar degenerative disc disease treatment, driven by rapidly developing healthcare infrastructure, increasing disposable incomes, and a rising prevalence of lifestyle-induced spinal conditions.

Countries including China and India are at the forefront due to their large population base, increasing elderly population, and growing awareness of treatment options. Moreover, governments in these countries are increasingly investing in healthcare, further fueling market growth. The EMEA region presents a diverse market scenario. Europe, being more developed, shows a higher need for advanced treatments driven by an increase in the aging population, high healthcare expenditure, and established healthcare systems. On the other hand, the Middle East and Africa are emerging markets with growing potential, mainly due to improving healthcare infrastructure, economic development, and a burgeoning middle class. However, the market growth in the African region is somewhat hampered by the lack of awareness and limited access to healthcare facilities.

Market Trends by Segment

  • Treatment: Rising usage of epidural steroid injections (ESIs) for management of lumbar degenerative disc disease
  • End-Users: Increasing need for lumbar degenerative disc disease treatment for diagnosing, treating, and managing patients

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Clears ReGelTec's HYDRAFIL System for Treatment of Lumbar Degenerative Disc Disease

The US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) to ReGelTec for their innovative HYDRAFIL system, designed to address lumbar degenerative disc disease. This device utilizes a unique polymer injected into the affected disc, which then solidifies to replicate the natural disc's biomechanical attributes.

RIT Researchers Awarded NIH Grant to CRISPR-Enhanced Stem Cell Therapy for Lumbar Degeneration

Researchers at the Rochester Institute of Technology, Karin Wuertz-Kozak, and Thomas Gaborski, were awarded a National Institutes of Health grant totaling USD 420,040 to explore the therapeutic potential of CRISPR-activated mesenchymal stem cells for treating Lumbar Degenerative Disc Disease. With a combination of Wuertz-Kozak's expertise in regenerative medicine and Gaborski's in nanomembrane technologies, this two-year study aims to address the challenges of direct stem cell therapies by exploring the therapeutic effectiveness of size-sorted EVs in vitro, utilizing disc cells from partner institutions like the University of Rochester.

Companion Spine Advances Global Spine Health with Strategic Acquisition of Backbone SAS

Companion Spine enhanced its medical implant solutions portfolio through the strategic acquisition of Backbone SAS, a company based in Bordeaux, France, known for its innovative functional motion restoration devices, including the flagship LISA (Lumbar Implant for Stiffness Augmentation) implant, tailored for spinal disorder treatments. Further solidifying this commitment, the acquisition augments Companion Spine's relationship with the University of Bordeaux's School of Spine Surgery, enhancing its contribution to global public health by addressing back pain and spinal diseases through innovative medical tools and implants.

Key Company Profiles

The report delves into recent significant developments in the Lumbar Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AnGes MG, Inc., AxioMed LLC, B. Braun SE, Baxter International Inc., Benvenue Medical, Inc., Biopharm GmbH, Boston Scientific Corporation, Centinel Spine, LLC, Cerapedics Inc., ChoiceSpine, DePuy Synthes by Medical Device Business Services, Inc., Globus Medical, Inc., Kolon TissueGene Inc., Kuros Biosciences, Lineage Cell Therapeutics, Inc., Medtronic plc, NLC Ventures Netherlands B.V., Notogen, Inc., Orthofix Medical Inc., RTI Surgical Holdings, Inc., Stryker Corporation, Ulrich Medical USA Inc., Veritas Health, LLC, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc.

This research report offers invaluable insights into various crucial aspects of the Lumbar Degenerative Disc Disease Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lumbar degenerative disc disease
5.1.1.2. Rising awareness campaigns and education about LDDD
5.1.2. Restraints
5.1.2.1. Limited availability of reimbursement
5.1.3. Opportunities
5.1.3.1. Ongoing R&D for introducing new LDDD treatments and diagnosis
5.1.3.2. Favorable government approvals for LDDD medicine commercialization
5.1.4. Challenges
5.1.4.1. Complexity in surgical procedures and medicine development
5.2. Market Segmentation Analysis
5.2.1. Treatment: Rising usage of epidural steroid injections (ESIs) for management of lumbar degenerative disc disease
5.2.2. End-Users: Increasing need for lumbar degenerative disc disease treatment for diagnosing, treating, and managing patients
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Lumbar Degenerative Disc Disease Market, by Treatment
6.1. Introduction
6.2. Epidural Steroid Injections (ESIs)
6.3. Over-the-counter (OTC) Pain Medications
6.4. Therapy Devices
7. Lumbar Degenerative Disc Disease Market, by Route of Administration
7.1. Introduction
7.2. Injectables
7.3. Oral
8. Lumbar Degenerative Disc Disease Market, by End-Users
8.1. Introduction
8.2. Academic Research Centers
8.3. Hospitals & Clinics
8.4. Specialty Clinics
9. Americas Lumbar Degenerative Disc Disease Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Lumbar Degenerative Disc Disease Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Lumbar Degenerative Disc Disease Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FDA Clears ReGelTec's HYDRAFIL System for Treatment of Lumbar Degenerative Disc Disease
12.3.2. RIT Researchers Awarded NIH Grant to CRISPR-Enhanced Stem Cell Therapy for Lumbar Degeneration
12.3.3. Companion Spine Advances Global Spine Health with Strategic Acquisition of Backbone SAS
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
FIGURE 2. LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LUMBAR DEGENERATIVE DISC DISEASE MARKET DYNAMICS
FIGURE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. LUMBAR DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. LUMBAR DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTIONS (ESIS), BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTIONS (ESIS), BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NARCOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NARCOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INJECTABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 67. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 68. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 69. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 70. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 71. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 72. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 73. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 74. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 75. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 76. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 77. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 78. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 79. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 80. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 81. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 82. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 111. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 112. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 113. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 114. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 115. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 116. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 117. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 118. CHINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 119. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 120. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 121. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 122. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 123. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 124. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 125. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 126. INDIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 135. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 136. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 137. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 138. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 139. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 140. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 141. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 142. JAPAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 183. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 184. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 185. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 186. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 187. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 188. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 189. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 190. THAILAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 209. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 210. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 211. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 212. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 213. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 214. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 215. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 216. DENMARK LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 217. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 218. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 219. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 220. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 221. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 222. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 223. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 224. EGYPT LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 225. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 226. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 227. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 228. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 229. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 230. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 231. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 232. FINLAND LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 233. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 234. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 235. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 236. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 237. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 238. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 239. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 240. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 241. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 242. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 243. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 244. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 245. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 246. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 247. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 248. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 257. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 258. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 259. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 260. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 261. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 262. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 263. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 264. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 281. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 282. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 283. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 284. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PAIN MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 285. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 286. NORWAY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ROUTE

Companies Mentioned

  • Abbott Laboratories
  • AnGes MG, Inc.
  • AxioMed LLC
  • B. Braun SE
  • Baxter International Inc.
  • Benvenue Medical, Inc.
  • Biopharm GmbH
  • Boston Scientific Corporation
  • Centinel Spine, LLC
  • Cerapedics Inc.
  • ChoiceSpine
  • DePuy Synthes by Medical Device Business Services, Inc.
  • Globus Medical, Inc.
  • Kolon TissueGene Inc.
  • Kuros Biosciences
  • Lineage Cell Therapeutics, Inc.
  • Medtronic plc
  • NLC Ventures Netherlands B.V.
  • Notogen, Inc.
  • Orthofix Medical Inc.
  • RTI Surgical Holdings, Inc.
  • Stryker Corporation
  • Ulrich Medical USA Inc.
  • Veritas Health, LLC
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 796.33 Million
Forecasted Market Value ( USD ) by 2030 $ 1207.76 Million
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Image

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • 181 Pages
  • Global
From
Global Degenerative Disc Disease Market by Product Type (Devices, Drugs), Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine), End-Users - Forecast 2024-2030 - Product Image

Global Degenerative Disc Disease Market by Product Type (Devices, Drugs), Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine), End-Users - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032 - Product Image

Degenerative Disc Disease - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • 161 Pages
  • Global
From
Degenerative Disc Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Image

Degenerative Disc Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • 89 Pages
  • Global
From
Degenerative Disc Disease - Pipeline Insight, 2024 - Product Image

Degenerative Disc Disease - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.